Quantum Computing for Drug Discovery & Development
Quantum computing keeps coming up as one of the technologies that could reshape pharma R&D. Join AION Labs, Qubit IL Israel's Quantum Tech Association, and Amiti for Quantum Computing for Drug Discovery & Development event, an evening bringing together people from both sides of the equation: quantum enthusiasts curious about biology, and drug-discovery people curious about what quantum could unlock. We’ll hear directly from pioneers already building in the space, get everyone on the same page with short intros to both worlds, and ask leaders from pharma, quantum and venture how they are thinking about the road ahead. Agenda: - Quantum Computing 101: Emanuele Dalla Torre, Cheif Scientist, QuantyMize - Drug Discovery 101: Tal Leibovich, COO and Co-Founder, DenovAI - Startup spotlights: Tidhar Turgeman, Head of Clinical Trials - Quantum X Labs Yoav Kimchy, Founder and CEO, Qubicalz - Panel: Quantum in Pharma R&D, moderated by Ram Waisbourd (Venture Partner, AION Labs): Karin Noy (Senior Director, Emerging Science & Innovation Lead Technology & AI, Pfizer) Tal David (Co-Founder and CEO, Quantum Art) Ben Rabinowitz (Managing Partner and Founder, Amiti) Register now - spots are limited